Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | +1.69% |
|
-2.69% | -9.05% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.05% | 31.45M | |
+20.64% | 85.53B | |
-28.19% | 71.18B | |
-0.49% | 26.41B | |
+1.75% | 17.32B | |
-10.31% | 17.18B | |
+2.19% | 15.65B | |
+78.22% | 13.71B | |
+79.75% | 13.27B | |
-23.16% | 13.28B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases